Johnson & Johnson Is Exploring Bid for Intra-Cellular Therapies

Estimated read time 1 min read


Johnson & Johnson is exploring a bid to acquire Intra-Cellular Therapies Inc., a biopharmaceutical company focused on treatments for central nervous system disorders, people familiar with the matter said.

Source link

You May Also Like

More From Author

+ There are no comments

Add yours